Evidence map›Paper›PMID 29984746›Full record

ArticleInternal medicine (Tokyo, Japan)2018

Combined Coagulopathy Can Induce Both Hemorrhagic and Thrombotic Complications in Multiple Myeloma.

Ichiro Kawashima, Katsuhiro Takano, Takuma Kumagai, Megumi Koshiishi, Saori Oishi, Yuki Sueki, Kei Nakajima, Toru Mitsumori, Keita Kirito

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ichiro KawashimaDepartment of Hematology and Oncology, University of Yamanashi, Japan.
Katsuhiro TakanoClinical and Laboratory Medicine, University of Yamanashi, Japan.
Takuma KumagaiDepartment of Hematology and Oncology, University of Yamanashi, Japan.
Megumi KoshiishiDepartment of Hematology and Oncology, University of Yamanashi, Japan.
Saori OishiDepartment of Hematology and Oncology, University of Yamanashi, Japan.
Yuki SuekiDepartment of Hematology and Oncology, University of Yamanashi, Japan.
Kei NakajimaDepartment of Hematology and Oncology, University of Yamanashi, Japan.
Toru MitsumoriDepartment of Hematology and Oncology, University of Yamanashi, Japan.
Keita KiritoDepartment of Hematology and Oncology, University of Yamanashi, Japan.
University of Yamanashi · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coagulation abnormalities are a rare but critical complication associated with plasma cell diseases. We herein present a case of multiple myeloma (MM) with complicated coagulopathy. Initially, the patient showed severe bleeding tendency due to concomitant acquired hemophilia A and acquired von Willebrand syndrome. Interestingly, the patient also exhibited hyperactivation of factor IX. During treatment for MM, the bleeding complications were ameliorated; however, the patient had central retinal vein occlusion. All of the coagulation abnormalities were completely resolved after the complete remission of MM. This case suggests that MM patients may have concomitant risks for both bleeding and thromboembolic complications.

Indexed as

FemaleHemophilia AHemorrhageHumansMaleMiddle AgedMultiple MyelomaThrombosisvon Willebrand Diseasesacquired hemophilia Aacquired von Willebrand diseasemultiple myeloma

Identifiers

PMID29984746
PMCPMC6287997
OpenAlexW2823132063

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.